Synjardy (empagliflozin and metformin hydrochloride)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
July 2016
BOX WARNING (revised as below)
WARNING: LACTIC ACIDOSIS
Postmarketing cases of metformin-associated lactic acidosis...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts